US EditionPublished • loading... • Updated
Swiss firm Ypsomed to build first U.S. plant, plans $200 million investment
Summary by WTVB
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Swiss firm Ypsomed to build first U.S. plant, plans $200 million investment
ZURICH (Reuters) -Swiss medical technology company Ypsomed said on Friday it will establish its first manufacturing facility in the United States with an initial $200 million investment in the town of Holly Springs, North Carolina. Ypsomed, a maker of self-injection systems, said it plans to create about 100 new jobs and wants to roughly double that number in the coming years as demand rises. The plant is due to begin supplying the U.S. market f…
The Swiss Medtech company chose Holly Springs in the state of North Carolina and invested around 200 million Swiss francs in a first phase.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
